Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Phosphatidylinositol-specific phospholipase C, X domain containing 1 pseudogene (PLCXD1 pseudogene) is a nonfunctional segment of DNA that resembles the gene encoding PI-PLC X domain-containing protein 1[5][4]. Pseudogenes arise from gene duplication or retrotransposition events and typically cannot produce a functional protein due to disabling mutations, lack of promoter regions, or other regulatory elements[4]. This pseudogene is annotated in genomic databases but does not encode the functional phosphatidylinositol-specific phospholipase C enzyme, nor is it considered a receptor, enzyme, or other therapeutically actionable target. Pseudogenes are generally not implicated in cellular signaling, disease mechanisms, or pharmacology[4][5]. If you require information on the functional form (i.e., PLCXD1 functional gene/protein), refer instead to ENSG00000182378, which encodes the actual enzyme relevant for lipid signaling[3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol-specific phospholipase C, X domain containing 1 pseudogene (PLCXD1 pseudogene).